EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction: Malacrida et al. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. Int. J. Mol. Sci. 2023, 24, 1721

Alessio Malacrida, Marie Deschamps-Wright, Roberta Rigolio, Guido Cavaletti iD, Mariarosaria Miloso iD

International Journal of Molecular Sciences · 07.07.2026 · 27 (13) · 6071

DOI: 10.3390/ijms27136071 ↗

Kurz gefasst

Korrektur in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.07.2026. Verfasst von Alessio Malacrida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the original publication [...]

Autor:innen und Institutionen

  • Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy.

ORCID-Profile: Guido Cavaletti, Mariarosaria Miloso

Zitieren

APA

Malacrida, A., Deschamps-Wright, M., Rigolio, R., Cavaletti, G., & Miloso, M. (2026). Correction: Malacrida et al. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. Int. J. Mol. Sci. 2023, 24, 1721. International Journal of Molecular Sciences, 27(13), 6071. https://doi.org/10.3390/ijms27136071

Vancouver

Malacrida A, Deschamps-Wright M, Rigolio R, Cavaletti G, Miloso M. Correction: Malacrida et al. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. Int. J. Mol. Sci. 2023, 24, 1721. International Journal of Molecular Sciences. 2026;27(13):6071. doi:10.3390/ijms27136071

BibTeX
@article{Malacrida2026,
  author = {Malacrida, Alessio and Deschamps-Wright, Marie and Rigolio, Roberta and Cavaletti, Guido and Miloso, Mariarosaria},
  title = {Correction: Malacrida et al. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. Int. J. Mol. Sci. 2023, 24, 1721},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {6071},
  doi = {10.3390/ijms27136071}
}
Kostenlos starten →